Brigham and Women's Hospital: Prostatic Neoplasms trials

The registry lists 15 Prostatic Neoplasms studies with Brigham and Women's Hospital as lead sponsor. 8 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 2Phase 3 1Phase 4 2No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of Boswellia for Urinary Toxicity in Prostate Cancer RadiotherapyNot yet recruitingNCT07867158Phase 2
• Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)RecruitingNCT07427043Phase 3
• MRI Guided Prostate BiopsyRecruitingNCT06302595Not applicable
• Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide TetraxetanRecruitingNCT06099093Phase 4
• Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CTRecruitingNCT06062745Phase 1
• Increasing Access to Definitive Treatment for Prostate CancerNot yet recruitingNCT06034431Not applicable
• Jump: MR Simulation For Radiation Therapy Master ProtocolRecruitingNCT04545957Not applicable
• Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate CancerEnrolling by invitationNCT04399876Phase 1
• The Use of Artificial Intelligence Generated Contours in Radiation Planning of the Prostate BrachytherapyActive, not recruitingNCT06964412Not applicable
• PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate CancerActive, not recruitingNCT06479187Phase 4
• A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of InterestCompletedNCT05899361Not applicable
• Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims DataCompletedNCT04897958
• INTREPId (INTermediate Risk Erection PreservatIon Trial)Active, not recruitingNCT04025372Phase 2
• Physicians' Health Study IICompletedNCT00270647Not applicable
• Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility TrialCompletedNCT00207259Not applicable